Search…

Hong Kong Technology: As of July 31, 2026, the repurchase has not yet commenced.

03/08/2026

Hong Kong Technology announced that on July 24, 2026, the company approved a repurchase plan, intending to buy back shares for no less than RMB 60 million and not exceeding RMB 90 million, with a repurchase price not exceeding RMB 100 per share. The repurchased shares will all be used for an employee stock ownership plan or equity incentive. As of July 31, 2026, the company has not yet started implementing the share repurchase.

Latest

1 m ago

The 14th Five-Year Plan for the Construction of a New Power System: Actively and safely develop nuclear power, aiming for approximately 110 million kilowatts of installed nuclear power capacity by 2030.

2 m ago

Changmao Biological (00954.HK) issued a profit warning, expecting that the interim net loss attributable to shareholders will narrow to between 4 million and 6 million yuan compared to the same period last year.

2 m ago

Tong Ren Tang Medical and Healthcare (02667.HK): The price stabilization period has ended, previously purchasing 5.4075 million shares of H-shares.

2 m ago

Lianhuan Pharmaceutical (600513.SH): Buprenorphine injection and other medications are expected to be selected for national centralized drug procurement.

2 m ago

The Financial Conduct Authority in the UK: shortening the deadline for correcting historical report errors from 5 years to 3 years.

See all latest